Listen

Description

In this episode of Doctors Take the Mic, Dr. Gloria Wu discusses Valeda photobiomodulation (light therapy), an FDA-approved treatment designed for patients with dry age-related macular degeneration (AMD) presenting with large drusen (greater than 150 microns). Dr. Wu explains how excess light exposure triggers oxidative stress in the retinal pigment epithelium—the cellular waste disposal system of the retina—resulting in the accumulation of lipid-rich drusen along Bruch's membrane. Drawing parallels to red-light therapy used in dermatology to stimulate mitochondrial energy and reduce oxidative damage, she details how Valeda's multi-session protocol (nine treatments over two to three weeks) helps alter drusen appearance and expands therapeutic options beyond traditional AREDS 2 vitamins and dietary modifications.